Effect of regional citrate anticoagulation on leukopenia, complement activation, and expression of leukocyte surface molecules during hemodialysis with unmodified cellulose membranes
A. Dhondt et al., Effect of regional citrate anticoagulation on leukopenia, complement activation, and expression of leukocyte surface molecules during hemodialysis with unmodified cellulose membranes, NEPHRON, 85(4), 2000, pp. 334-342
Background: Dialysis with complement-activating membranes is associated wit
h leukopenia, which is related to an increased expression of adhesion molec
ules on leukocytes. Citrate chelates calcium and has been claimed to attenu
ate leukopenia. Methods: In this study, the effects of citrate anticoagulat
ion on leukocyte and granulocyte counts, complement activation, and the exp
ression of CD11b, CD11c, and CD45 on the surface of granulocytes were evalu
ated during hemodialysis with unmodified cellulose membranes. Standard hepa
rin was compared to citrate in three different schedules: citrate was infus
ed to obtain a concentration of either 7 or 10 mmol/l blood. CaCl2 was admi
nistered into the dialyzer outlet at 8.25 mmol Ca2+/h (citrate 10 mmol/l) o
r at 11 mmol Ca2+/h (citrate 7 and 10 mmol/l) to restitute the calcium leve
ls in the blood returning to the patient. Results: The use of citrate at a
high concentration (10 mmol/l) was associated with a blunted upregulation o
f CD11b, both at the inlet and at the outlet bloodline; for CD11c a reduced
upregulation was observed on granulocytes harvested from the inlet bloodli
ne. No effects of citrate were observed on leukopenia, granulocytopenia, or
complement activation. A positive correlation between the decrease in syst
emic ionized Ca2+ concentration and the increase in CD11b and CD11c express
ion was found. Conclusion: Citrate/CaCl2 administration affects leukocyte a
dhesion molecule expression in a dose-dependent way; however, no significan
t effect could be demonstrated on leukopenia and complement activation. Cop
yright (C) 2000 S. Karger AG, Basel.